Author:
Belfort Gabriel M.,Harrison Boyd L.,Martinez Botella Gabriel
Publisher
Wiley-VCH Verlag GmbH & Co. KGaA
Reference28 articles.
1. Ferlay , J. Soerjomataram , I. Ervik , M. Dikshit , R. Eser , S. Mathers , C. Rebelo , M. Parkin , D.M. Forman , D. Bray , F. 2014 GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] Lyon, France International Agency for Research on Cancer http://globocan.iarc.fr
2. Cancer Statistics, 2016;Siegel;CA Cancer J Clin.,2016
3. Translating scientific advancement into clinical benefit for castration-resistant prostate cancer patients;Attard;Clin. Cancer Res.,2011
4. Prednisone plus cabazitaxel or mitoxantrone for metastatic castratio-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;Bono;Lancet,2010
5. Integrated data from 2 randomised, double blind, placebo controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advance prostate cancer;Higano;Cancer,2009
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献